TherapeuticsMD Inc

Company Profile

TherapeuticsMD Inc had its IPO on 2003-12-11 under the ticker symbol TXMD.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. TherapeuticsMD Inc has a staff strength of 1 employees.

Stock update

Shares of TherapeuticsMD Inc opened at $3.59 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.59 - $3.72, and closed at $3.62.

This is a -0.28% slip from the previous day's closing price.

A total volume of 21,485 shares were traded at the close of the day’s session.

In the last one week, shares of TherapeuticsMD Inc have slipped by -4.23%.

TherapeuticsMD Inc's Key Ratios

TherapeuticsMD Inc has a market cap of $38.39 million, indicating a price to book ratio of 40.7475 and a price to sales ratio of 0.7174.

In the last 12-months TherapeuticsMD Inc’s revenue was $69.77 million with a gross profit of $68.11 million and an EBITDA of $38.99 million. The EBITDA ratio measures TherapeuticsMD Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, TherapeuticsMD Inc’s operating margin was 54.83% while its return on assets stood at 23.92% with a return of equity of 11.34%.

In Q2, TherapeuticsMD Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 25.6%.

TherapeuticsMD Inc’s PE and PEG Ratio

Forward PE

2.291

Trailing PE

1.0772

PEG

-0.73

Its diluted EPS in the last 12-months stands at $3.37 per share while it has a forward price to earnings multiple of 2.291 and a PEG multiple of -0.73. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into TherapeuticsMD Inc’s profitability.

TherapeuticsMD Inc stock is trading at a EV to sales ratio of 1.6199 and a EV to EBITDA ratio of 17.5384. Its price to sales ratio in the trailing 12-months stood at 0.7174.

TherapeuticsMD Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$53.69 million

Total Liabilities

$14.36 million

Operating Cash Flow

$0

Capital Expenditure

$10000

Dividend Payout Ratio

0%

TherapeuticsMD Inc ended 2023 with $53.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.69 million while shareholder equity stood at $31.20 million.

TherapeuticsMD Inc ended 2023 with $0 in deferred long-term liabilities, $14.36 million in other current liabilities, 11000.00 in common stock, $-945380000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $13.73 million and cash and short-term investments were $13.73 million. The company’s total short-term debt was $1,448,000 while long-term debt stood at $0.

TherapeuticsMD Inc’s total current assets stands at $19.61 million while long-term investments were $0 and short-term investments were $68410.00. Its net receivables were $1.04 million compared to accounts payable of $1.51 million and inventory worth $3.40 million.

In 2023, TherapeuticsMD Inc's operating cash flow was $0 while its capital expenditure stood at $10000.

Comparatively, TherapeuticsMD Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$3.62

52-Week High

$8.67

52-Week Low

$3.25

Analyst Target Price

$5

TherapeuticsMD Inc stock is currently trading at $3.62 per share. It touched a 52-week high of $8.67 and a 52-week low of $8.67. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $3.94 and 200-day moving average was $4.43 The short ratio stood at 16.02 indicating a short percent outstanding of 0%.

Around 818.3% of the company’s stock are held by insiders while 4469% are held by institutions.